Cognex Corporation $CGNX Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC cut its stake in Cognex Corporation (NASDAQ:CGNX) by 3.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 56,525 shares of the scientific and technical instruments company’s stock after selling 1,890 shares during the quarter. Yousif Capital Management LLC’s holdings in Cognex were worth $1,793,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. M.E. Allison & CO. Inc. acquired a new position in shares of Cognex during the 2nd quarter worth approximately $262,000. CWM LLC raised its stake in shares of Cognex by 145.2% during the 2nd quarter. CWM LLC now owns 117,039 shares of the scientific and technical instruments company’s stock worth $3,712,000 after buying an additional 69,307 shares during the period. Vanguard Personalized Indexing Management LLC raised its stake in shares of Cognex by 120.7% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 37,224 shares of the scientific and technical instruments company’s stock worth $1,181,000 after buying an additional 20,357 shares during the period. Inspire Investing LLC raised its stake in shares of Cognex by 6.3% during the 2nd quarter. Inspire Investing LLC now owns 12,316 shares of the scientific and technical instruments company’s stock worth $391,000 after buying an additional 725 shares during the period. Finally, JB Capital LLC raised its stake in shares of Cognex by 8.9% during the 2nd quarter. JB Capital LLC now owns 50,277 shares of the scientific and technical instruments company’s stock worth $1,595,000 after buying an additional 4,101 shares during the period. 88.12% of the stock is owned by institutional investors and hedge funds.

Cognex Stock Performance

NASDAQ CGNX opened at $46.04 on Monday. The business has a fifty day moving average price of $44.62 and a 200 day moving average price of $35.51. Cognex Corporation has a one year low of $22.67 and a one year high of $47.52. The company has a market cap of $7.73 billion, a P/E ratio of 64.85 and a beta of 1.50.

Cognex (NASDAQ:CGNX) last issued its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $249.09 million during the quarter, compared to analysts’ expectations of $246.70 million. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, sell-side analysts predict that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex’s dividend payout ratio is presently 45.07%.

Analyst Ratings Changes

Several research analysts have recently weighed in on CGNX shares. JPMorgan Chase & Co. started coverage on Cognex in a research note on Monday, September 15th. They set a “neutral” rating and a $45.00 target price for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a research note on Wednesday, October 8th. The Goldman Sachs Group increased their price objective on Cognex from $36.00 to $40.00 and gave the company a “sell” rating in a research note on Tuesday, September 16th. KeyCorp raised Cognex from a “sector weight” rating to an “overweight” rating and set a $50.00 price objective for the company in a research note on Friday, August 1st. Finally, Barclays set a $55.00 price objective on Cognex and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $44.93.

Insider Transactions at Cognex

In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the completion of the sale, the executive vice president directly owned 6,582 shares in the company, valued at $296,387.46. This represents a 23.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is currently owned by insiders.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.